about
An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomasIntegrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas.Gene expression profiling in leiomyosarcomas and undifferentiated pleomorphic sarcomas: SRC as a new diagnostic marker.Genomic signatures predict poor outcome in undifferentiated pleomorphic sarcomas and leiomyosarcomas.Down-Regulation of SLC8A1 as a Putative Apoptosis Evasion Mechanism by Modulation of Calcium Levels in Penile Carcinoma.Genome-wide methylation and transcriptome analysis in penile carcinoma: uncovering new molecular markers.Molecular Expression Profile Reveals Potential Biomarkers and Therapeutic Targets in Canine Endometrial Lesions.DNA methylation patterns of candidate genes regulated by thymine DNA glycosylase in patients with TP53 germline mutations.Integrative miRNA and mRNA analysis in penile carcinomas reveals markers and pathways with potential clinical impact.Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma.Genomic copy number variation associated with clinical outcome in canine cutaneous mast cell tumors.Disruption of prion protein-HOP engagement impairs glioblastoma growth and cognitive decline and improves overall survival.Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.An Integrative Approach Uncovers Biomarkers that Associate with Clinically Relevant Disease Outcomes in Vulvar Carcinoma.HABP2 p.G534E variant in patients with family history of thyroid and breast cancer.Genomic profiling of human penile carcinoma predicts worse prognosis and survival.Genomic screening of testicular germ cell tumors from monozygotic twinsGenome-wide DNA methylation profile of leukocytes from melanoma patients with and without CDKN2A mutations.High Diagnostic Accuracy Based on CLDN10, HMGA2, and LAMB3 Transcripts in Papillary Thyroid Carcinoma.A comprehensive characterization of cell cultures and xenografts derived from a human verrucous penile carcinoma.Comprehensive Genomic Profiling of Androgen-Receptor-Negative Canine Prostate Cancer
P50
Q28487526-88A5BFC0-6442-4EAD-96E1-A73025090D3DQ33629836-99E4069F-7881-4D93-A40A-D79F7E2A244DQ33910538-B36EE946-4E00-43F8-852E-5AFEBC3B4E01Q34795063-399D2DE5-A5B7-418C-9CFE-155DC11C1970Q35496045-A2DE98F8-7B90-422B-8538-2AB5295EE765Q35532064-8032DE29-15EC-42C7-80BB-5A32B6CD9BEDQ35723326-A16609D2-1410-4A9A-9F53-00EB1F2505C8Q35881338-3992600C-EDCF-4AB0-BEEA-2D57EF80DA69Q37716542-E9F0AAE7-7F53-450A-9BD4-C5D3FBA3B7D2Q38656476-61D4C783-5145-4FF5-83F7-39547F6A7E8DQ38925537-54B93D64-23B5-4C37-ADCD-F01826773C1DQ38963334-1B479C51-17E8-4C35-92BD-1D9B800DB5DDQ39532008-7BA61891-5960-43E2-A5FD-654690AB6A72Q39773461-949E38C2-816B-46D3-ABB7-BAD580F9013DQ40245949-35BEAE09-19F0-452A-8B3D-9978E9D2DA91Q41601717-601523A8-7DE7-4F6A-B2C8-E0E8013BEB2CQ41952598-58123274-94DE-47E4-BCD2-2C74384579C5Q46506746-D2476750-5E9E-4997-AD91-3FA8E62C0F0AQ50932708-9DC087BC-38CE-4CA6-BF9B-BA9AB88DAA57Q53152595-A38057D7-FE69-4541-87CB-A7D50A27B47EQ64107503-7FAE55CD-81D5-4792-8F89-9B4E98E49086
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fabio Marchi
@ast
Fabio Marchi
@en
Fabio Marchi
@es
Fabio Marchi
@nl
Fabio Marchi
@sl
type
label
Fabio Marchi
@ast
Fabio Marchi
@en
Fabio Marchi
@es
Fabio Marchi
@nl
Fabio Marchi
@sl
prefLabel
Fabio Marchi
@ast
Fabio Marchi
@en
Fabio Marchi
@es
Fabio Marchi
@nl
Fabio Marchi
@sl
P1053
E-6928-2014
P106
P21
P31
P496
0000-0001-5815-8423